212 related articles for article (PubMed ID: 17703463)
1. Docking study and free energy simulation of the complex between p53 DNA-binding domain and azurin.
De Grandis V; Bizzarri AR; Cannistraro S
J Mol Recognit; 2007; 20(4):215-26. PubMed ID: 17703463
[TBL] [Abstract][Full Text] [Related]
2. Modeling the interaction between the N-terminal domain of the tumor suppressor p53 and azurin.
Taranta M; Bizzarri AR; Cannistraro S
J Mol Recognit; 2009; 22(3):215-22. PubMed ID: 19140135
[TBL] [Abstract][Full Text] [Related]
3. A combined atomic force microscopy imaging and docking study to investigate the complex between p53 DNA binding domain and Azurin.
Bizzarri AR; Di Agostino S; Andolfi L; Cannistraro S
J Mol Recognit; 2009; 22(6):506-15. PubMed ID: 19642109
[TBL] [Abstract][Full Text] [Related]
4. Unique complex between bacterial azurin and tumor-suppressor protein p53.
Apiyo D; Wittung-Stafshede P
Biochem Biophys Res Commun; 2005 Jul; 332(4):965-8. PubMed ID: 15913547
[TBL] [Abstract][Full Text] [Related]
5. Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain.
Butler JS; Loh SN
Biochemistry; 2003 Mar; 42(8):2396-403. PubMed ID: 12600206
[TBL] [Abstract][Full Text] [Related]
6. Effect of Zn2+ on DNA recognition and stability of the p53 DNA-binding domain.
Duan J; Nilsson L
Biochemistry; 2006 Jun; 45(24):7483-92. PubMed ID: 16768444
[TBL] [Abstract][Full Text] [Related]
7. The interaction of azurin and C-terminal domain of p53 is mediated by nucleic acids.
Xu C; Zhao Y; Zhao B
Arch Biochem Biophys; 2010 Nov; 503(2):223-9. PubMed ID: 20800053
[TBL] [Abstract][Full Text] [Related]
8. Probing the interaction between p53 and the bacterial protein azurin by single molecule force spectroscopy.
Taranta M; Bizzarri AR; Cannistraro S
J Mol Recognit; 2008; 21(1):63-70. PubMed ID: 18247358
[TBL] [Abstract][Full Text] [Related]
9. Energetics of sequence-specific protein-DNA association: computational analysis of integrase Tn916 binding to its target DNA.
Gorfe AA; Jelesarov I
Biochemistry; 2003 Oct; 42(40):11568-76. PubMed ID: 14529266
[TBL] [Abstract][Full Text] [Related]
10. Structural characteristics of the hydrophobic patch of azurin and its interaction with p53: a site-directed spin labeling study.
Xu C; Yin J; Zhao B
Sci China Life Sci; 2010 Oct; 53(10):1181-8. PubMed ID: 20953940
[TBL] [Abstract][Full Text] [Related]
11. Modelling the interaction between the p53 DNA-binding domain and the p28 peptide fragment of Azurin.
Santini S; Bizzarri AR; Cannistraro S
J Mol Recognit; 2011; 24(6):1043-55. PubMed ID: 22038811
[TBL] [Abstract][Full Text] [Related]
12. Docking of antizyme to ornithine decarboxylase and antizyme inhibitor using experimental mutant and double-mutant cycle data.
Cohavi O; Tobi D; Schreiber G
J Mol Biol; 2009 Jul; 390(3):503-15. PubMed ID: 19465028
[TBL] [Abstract][Full Text] [Related]
13. Raman Evidence of p53-DBD Disorder Decrease upon Interaction with the Anticancer Protein Azurin.
Signorelli S; Cannistraro S; Bizzarri AR
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31238511
[TBL] [Abstract][Full Text] [Related]
14. Computational screening and design of S100B ligand to block S100B-p53 interaction.
Whitlow JL; Varughese JF; Zhou Z; Bartolotti LJ; Li Y
J Mol Graph Model; 2009; 27(8):969-77. PubMed ID: 19324580
[TBL] [Abstract][Full Text] [Related]
15. The early steps in the unfolding of azurin.
Rizzuti B; Daggett V; Guzzi R; Sportelli L
Biochemistry; 2004 Dec; 43(49):15604-9. PubMed ID: 15581373
[TBL] [Abstract][Full Text] [Related]
16. Docking and molecular dynamics simulation of the Azurin-Cytochrome c551 electron transfer complex.
Bizzarri AR; Brunori E; Bonanni B; Cannistraro S
J Mol Recognit; 2007; 20(2):122-31. PubMed ID: 17407190
[TBL] [Abstract][Full Text] [Related]
17. Predicting the coordination geometry for Mg2+ in the p53 DNA-binding domain: insights from computational studies.
Wang T; Shao X; Cai W; Xue Y; Wang S; Feng X
Phys Chem Chem Phys; 2011 Jan; 13(3):1140-51. PubMed ID: 21076775
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the anticancer p28 peptide with p53-DBD as studied by fluorescence, FRET, docking and MD simulations.
Bizzarri AR; Moscetti I; Cannistraro S
Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):342-350. PubMed ID: 30419285
[TBL] [Abstract][Full Text] [Related]
20. Structure of the human p53 core domain in the absence of DNA.
Wang Y; Rosengarth A; Luecke H
Acta Crystallogr D Biol Crystallogr; 2007 Mar; 63(Pt 3):276-81. PubMed ID: 17327663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
